Bienville Capital Management’s Calumet Specialty Products CLMT Stock Holding History

Bienville Capital Management’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-341,102	Closed	-$6.08M	–	79
2024 Q3	$6.08M	Hold	341,102	–	–	1.57%	25
2024 Q2	$5.47M	Hold	341,102	–	–	1.31%	28
2024 Q1	$5.07M	Buy	341,102 +1	+0%	+$16	1.54%	23
2023 Q4	$6.1M	Hold	341,101	–	–	1.65%	18
2023 Q3	$6.52M	Hold	341,101	–	–	1.81%	14
2023 Q2	$5.41M	Sell	341,101 -15,001	-4%	-$247K	1.81%	15
2023 Q1	$6.19M	Hold	356,102	–	–	2.24%	15
2022 Q4	$6.01M	Buy	356,102 +71,500	+25%	+$1.15M	1.81%	13
2022 Q3	$3.65M	Buy	284,602 +15,000	+6%	+$215K	1.43%	18
2022 Q2	$2.8M	Buy	269,602 +16,788	+7%	+$223K	1.33%	20
2022 Q1	$3.44M	Buy	+252,814	New	+$3.72M	1.69%	13

Other funds holding CLMT

WDOM

Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return

AAA

Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMKJ

David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return

Bienville Capital Management's CLMT Position: Q4 2024 in Review

Bienville Capital Management sold out of Calumet Specialty Products (CLMT) in Q4 2024, closing a stake of 341,102 shares — an estimated $6.08M sold.

Bienville Capital Management first reported a position in CLMT in Q1 2022 and held it in 11 quarters. The position peaked at $6.52M in Q3 2023. 123 funds tracked by Wall St. Rank hold CLMT as of Q4 2024.

Bienville Capital Management reported no remaining Calumet Specialty Products position as of Q4 2024 after selling out during the quarter.
Bienville Capital Management sold 341,102 Calumet Specialty Products shares in Q4 2024, an estimated $6.08M.
Bienville Capital Management first reported a position in Calumet Specialty Products in Q1 2022 and held it in 11 quarters.
Bienville Capital Management's Calumet Specialty Products position peaked at $6.52M in Q3 2023.
123 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q4 2024.

Based on Bienville Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.